Key result
Familial Chylomicronemia Syndrome had a major impact on quality of life for nearly all 60 surveyed patients, who on average cycled through 5 physicians before receiving a diagnosis.
Cross-Sectional (n=60)
Familial chylomicronemia syndrome imposes a significant burden on patients' quality of life, daily activities, and employment, often following a lengthy diagnostic journey.
Answers are grounded in this paper and cite their sources.
FCS patients report major multi-domain impairments in daily life and employment; leaves open prospective quantification and therapy impact on burden.
BACKGROUND: Familial Chylomicronemia Syndrome (FCS) is a rare genetic disorder that is caused by a decrease or an absence of lipoprotein lipase activity. FCS is characterized by marked accumulation of chylomicrons and extreme hypertriglyceridemia, which have major effects on both physical and mental health. To date, there have been no systematic efforts to characterize the impact of chylomicronemia on FCS patients' lives. In particular, the impact of FCS on the burden of illness (BoI) and quality of life (QoL) has not been fully described in the literature. METHODS: IN-FOCUS was a comprehensive web-based research survey of patients with FCS focused on capturing the BoI and impact on QoL associated with FCS. Sixty patients from the US diagnosed with FCS participated. Patients described multiple symptoms spanning across physical, emotional and cognitive domains. RESULTS: Patients on average cycled through 5 physicians of varying specialty before being diagnosed with FCS, reflecting a lengthy journey to diagnosis Nearly all respondents indicated that FCS had a major impact on BoI and QoL and significantly influenced their career choice and employment status, and caused significant work loss due to their disease. CONCLUSION: FCS imparts a considerable burden across multiple domains with reported impairment on activities of daily living and QoL.
No takes yet. Share an insight, caveat, or question.
Davidson et al. (2017) conducted a cross-sectional in Familial Chylomicronemia Syndrome (n=60). Familial Chylomicronemia Syndrome was evaluated on Burden of illness and quality of life. Familial Chylomicronemia Syndrome had a major impact on quality of life for nearly all 60 surveyed patients, who on average cycled through 5 physicians before receiving a diagnosis.
Synapse has enriched 10 related papers. Consider them for comparative context: